New study tests safer stroke prevention for frail seniors with AFib
NCT ID NCT07441382
First seen Mar 07, 2026 · Last updated May 07, 2026 · Updated 9 times
Summary
This study compares two treatments for elderly frail patients with atrial fibrillation (AFib) who are at high risk for both stroke and bleeding. One group gets a heart procedure (catheter ablation) plus a device to close off a part of the heart (left atrial appendage occlusion), while the other group gets ablation plus blood-thinning medication. The goal is to see which approach better prevents strokes and major bleeding over one year. The study will enroll 200 participants aged 75 and older.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.